Viewing Study NCT02933320

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-24 @ 5:43 AM
Study NCT ID: NCT02933320
Status: COMPLETED
Last Update Posted: 2021-07-08
First Post: 2016-09-26
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
Sponsor: Cancer Research UK
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Lymphoma View
None Chronic Lymphocytic Leukaemia View
None Waldenström Macroglobulinemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Indolent B-cell Lymphoma View
None Chronic Lymphocytic Leukaemia View
None Waldenström Macroglobulinemia View
None BI-1206 View
None CD32b View